Search for African vaccine site to deepen

Health experts have said Rwanda, Senegal and South Africa could be candidates because they either have existing vaccine expertise and production.

14 October 2021 | Economics

GISELDA VAGNONI AND EMILY ROE

Rwanda, Senegal and South Africa could be potential locations for Moderna's planned vaccine factory in Africa, the US drugmaker's co-founder and chairman said as it steps up its search for a site on the continent.

Moderna said last week it would build a plant in Africa to produce up to 500 million doses of vaccines a year, including its COVID-19 shot, as pressure grows on pharmaceutical companies to manufacture drugs in lower-income countries.

Noubar Afeyan, a biochemical engineer of Armenian origin who co-founded Moderna in 2010, said in an interview with Reuters late on Monday that the selection process would likely intensify now it has announced its Africa plans.

Health experts have said Rwanda, Senegal and South Africa could be candidates because they either have existing vaccine expertise and production, or have expressed an interest in developing such an industry.

Asked by Reuters whether those three countries were on Moderna's list of potential candidates, Afeyan said: "I can confirm that, yes."

He declined to give further details about which countries Moderna has been talking to as the selection process is ongoing.

"We know several countries that already have good healthcare systems and quite a lot of interest in working on this, so we will find partners," he said.

South Africa has a medical research capacity and a domestic pharmaceutical industry, Senegal's Pasteur Institute produces yellow fever vaccines and Rwanda has expressed interest in making vaccines and drugs. Some countries in North Africa, such as Tunisia and Egypt, also have pharmaceutical industries.

BOOSTER DECISION

In August, German drugmaker BionTech said it was considering building malaria and tuberculosis vaccine production sites in Rwanda and Senegal.

Public health and government officials in Africa welcomed the news last week, but said the plant won't address the continent's urgent need for Covid-19 vaccines now.

Under 5% of Africans have been fully vaccinated against Covid-19, the continent's top public health official, John Nkengasong, noted after Moderna's announcement.

Afeyan said the overall goal was to have a plant that could make multiple vaccines so that "in the future, if there is a pandemic, and there will certainly be, then we can very rapidly convert it and provide the vaccine security on the continent".

Afeyan's comments come as the US Food and Drug Administration (FDA) reviews the booster dose of Moderna's vaccine for adults, as well as it’s shot for teenagers.

A panel of independent FDA advisers will meet on Thursday to discuss the booster dose. He said Moderna's request for emergency authorisation for its teen shot filed in June has not been delayed, but rather boosters were considered a more urgent issue at the moment.

"I think they are sequencing decisions and evaluations and they are considering the booster decision more urgent," he said.

PATENTS

Moderna's plans in Africa comes as debate rages between drugmakers and governments about waiving intellectual property rights for Covid-19 vaccines to help end the pandemic and give more developing countries access to shots.

Politico reported last week that the US administration has urged Moderna to increase its vaccine production to boost donations to countries in need but the company is hesitating for fear it would be paid less for the shots it contributes.

"Our interests with the White House are common and that is to get as many ... vaccines as possible next year to low-income countries as we have this year. In that regard, we're similar," Afeyan said, when asked about the Politico report.

"I only know what the discussions with the White House have been, and I think they've been very constructive," he said.

Moderna said on Friday it aimed to deliver 1 billion doses of its Covid-19 vaccine to low-income countries in 2022, in addition to the doses it has already committed to the global vaccine-sharing programme COVAX.

These vaccines will be part of the 2 to 3 billion doses the company has forecast to produce next year.

Afeyan said the notion that Moderna was not ramping up production to meet the requirements of countries in need was inconsistent with simple arithmetic.

"OECD countries have a need for a billion doses. The only way the other two billion doses could be used is to be used in low- to middle-income countries," he said.

The focus now was on the mechanism for doing that, whether through COVAX or direct bilateral agreements, for example with the African Union or other constituencies. -Nampa/Reuters

Similar News

 

Investors spooked

15 hours ago | Economics

Jo-Maré Duddy – If government gets its way, the Investment Promotion and Facilitation Bill will become law this week, giving the trade minister sole power...

The recovery of the rental market flatlined

15 hours ago | Economics

PHILLEPUS UUSIKUAlthough rental markets across most advanced economies are on a path of recovery due to the resumption of “normal life”, improved pace of Covid-19...

SA's Covid-19 cases could triple this week

15 hours ago | Economics

ALEXANDER WINNING AND WENDELL ROELFSouth Africa's daily Covid-19 infection rate could triple to more than 10 000 by the end of this week as the...

Global jet fuel demand under pressure

15 hours ago | Economics

Global jet fuel markets stayed under pressure on Tuesday as more countries expanded border restrictions to keep the new Omicron coronavirus variant at bay, prompting...

Omicron raises new fears for world economy

15 hours ago | Economics

Delphine Touitou - Just as it was recovering from the body blow of the Covid-19 pandemic, the global economy has taken yet another hit from...

Ethiopia lifts suspension of collateralised loans

15 hours ago | Economics

Ethiopia’s central bank has lifted a suspension of lending by commercial banks to their customers using collateral such as property, the bank said on Monday.The...

China leader promises Africa 1 bln doses

15 hours ago | Economics

China's president pledged to offer Africa one billion Covid-19 vaccine doses on Monday, with the continent struggling to acquire enough jabs to immunise against the...

AfDB postpones investment forum

15 hours ago | Economics

The African Development Bank (AfDB) has postponed to an unspecified date its planned Dec. 1-3 investment forum in Abidjan, Ivory Coast, due to health concerns...

Pandemic to cost global tourism US$2 trillion in 2021

15 hours ago | Economics

Valentin Bontemps and Mathieu Gorse - The coronavirus pandemic will cost the global tourism sector US$2 trillion in lost revenue in 2021, the UN's tourism...

Draft consensus on future pandemic treaty

15 hours ago | Economics

Stephanie Nebehay - Member states of the World Health Organisation have reached a tentative consensus to negotiate a future agreement on preventing pandemics, bridging the...

Latest News

The recovery of the rental...

15 hours ago | Economics

PHILLEPUS UUSIKUAlthough rental markets across most advanced economies are on a path of recovery due to the resumption of “normal life”, improved pace of Covid-19...

Van Wyk reports ACC to...

15 hours ago | Justice

OGONE TLHAGE WINDHOEKFishrot lackey Nigel van Wyk, in a report to the Office of...

Defence grilled over unapproved weapons...

15 hours ago | Ministries

JEMIMA BEUKES WINDHOEKThe defence ministry has bought, without Treasury approval, weapons worth N$5 million from its own ammunition manufacturing company, Ndilimani...

Govt, unions in stalemate over...

15 hours ago | Labour

ESTER KAMATI WINDHOEKCivil servants will have to face another year without a salary increase as discussions, which took place on Monday, between...

SA's Covid-19 cases could triple...

15 hours ago | Economics

ALEXANDER WINNING AND WENDELL ROELFSouth Africa's daily Covid-19 infection rate could triple to more than 10 000 by the end of this week as the...

Global jet fuel demand under...

15 hours ago | Economics

Global jet fuel markets stayed under pressure on Tuesday as more countries expanded border restrictions to keep the new Omicron coronavirus variant at bay, prompting...

EDITORIAL: Pohamba is embossing himself

15 hours ago | Opinion

Former President Hifikepunye Pohamba has been in the news this week for unsavoury reasons.In strict law terms, Pohamba has every right to kick pensioner Amanda...

Omicron raises new fears for...

15 hours ago | Economics

Delphine Touitou - Just as it was recovering from the body blow of the Covid-19 pandemic, the global economy has taken yet another hit from...

Expats in Namibia: Tax considerations

15 hours ago | Business

Johan Nel - Namibia has a source-based tax system. Income that has accrued, or deemed to have accrued, from sources within Namibia will form part...

Load More